Quatre Lab

Quatre Lab operates as a Contract Research Organization (CRO) with a clear trajectory towards becoming a Good Manufacturing Practices (GMP) accredited pharmaceutical company under the Spanish Agency of Medicines and Medical Devices (AEMPS). The company was conceptualized and founded in late 2021 by the venture capital firm Columbus Venture Partners, which utilized its Life Sciences Fund III for the investment. Strategically located in the Miramón Technology Park in Gipuzkoa, Spain, the company secured its initial Research & Development clients and commenced construction of its GMP-compliant facilities in 2023. Additional backing comes from Gestión de Capital Riesgo del País Vasco, S.G.E.I.C., S.A. – Grupo SPRI.

The business provides specialized quality control (QC) services for Advanced Therapy Medicinal Products (ATMPs), catering to a client base that includes biotech companies, pharmaceutical enterprises, and both public and private health-related institutions. Its core service is to ensure that advanced therapies meet the rigorous safety, efficacy, and quality standards required by regulatory agencies for clinical trials and commercial market entry. The company's business model is centered on offering tailored, integrated QC services that cover the entire product lifecycle, from analytical method development and validation to routine testing and batch release. This includes specialized consulting to navigate complex validation and regulatory compliance challenges.

Quatre Lab's service portfolio is comprehensive, featuring assays to determine potency, purity, strength, and safety of ATMPs. They also provide services for cell banking validation and control. The company offers support across various development stages, including basic R&D, preclinical studies, and all clinical phases, ensuring adherence to GMP standards as required. A key aspect of their operation is a user-centered approach, where they collaborate closely with clients to design and develop customized quality control strategies and innovative R&D projects. In April 2025, Quatre Lab announced it had received AEMPS accreditation as an authorized pharmaceutical laboratory under GMP. The company is managed by a team of professionals with backgrounds in biomedical research, pharmacy, and quality assurance, led by Managing Director Patricia Muñoz, Ph.D.

Keywords: Contract Research Organization, CRO, Advanced Therapy Medicinal Products, ATMP, Quality Control, GMP, pharmaceutical services, biotech, regulatory compliance, AEMPS, quality assurance, cell banking, potency assays, purity testing, analytical method development, clinical trial support, pharmaceutical validation, life sciences, gene therapy, Columbus Venture Partners